Last 12 months
Inside the activity.
0 purchase rows · 153 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 25 |
| Dec 2025 | 0 | 13 |
| Jan 2026 | 0 | 14 |
| Feb 2026 | 0 | 24 |
| Mar 2026 | 0 | 12 |
| Apr 2026 | 0 | 9 |
| May 2026 | 0 | 23 |
| Jun 2026 | 0 | 20 |
| Jul 2026 | 0 | 4 |
| Aug 2026 | 0 | 7 |
| Sep 2026 | 0 | 2 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 16, 2021 Filed Aug 18, 2021 20:10 UTC |
STEPHENSON BRIAN CSee Remarks
|
Exercise / conversionRestricted Stock Units · Derivative | 1,709 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-033443 · doc4.xml · derivative · entry 3 STEPHENSON BRIAN C · CIK 0001780030 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,808 Underlying: Common Stock · 1,709 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. F3 · derivative.exercise_date: The RSUs vest in sixteen quarterly installments after May 16, 2020, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date, and have no expiration date. F3 · derivative.expiration_date: The RSUs vest in sixteen quarterly installments after May 16, 2020, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date, and have no expiration date. Read SEC document |
| August 16, 2021 Filed Aug 18, 2021 20:10 UTC |
STEPHENSON BRIAN CSee Remarks
|
Tax withholdingCommon Stock | 1,028 | $49.48 | $50,865.44 |
DisclosureSEC source: 0000899243-21-033443 · doc4.xml · nonDerivative · entry 2 STEPHENSON BRIAN C · CIK 0001780030 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 303,128 F2 · shares: Represents number of shares of the Issuer's Common Stock withheld to satisfy the Reporting Person's tax obligation in connection with the vesting of 2,487 shares of Common Stock underlying the Reporting Person's RSUs. Read SEC document |
| August 16, 2021 Filed Aug 18, 2021 20:10 UTC |
STEPHENSON BRIAN CSee Remarks
|
Exercise / conversionCommon Stock | 2,487 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-21-033443 · doc4.xml · nonDerivative · entry 1 STEPHENSON BRIAN C · CIK 0001780030 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 304,156 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document |
| August 16, 2021 Filed Aug 18, 2021 20:06 UTC |
Kumar NeilDirector · CEO and President
|
Exercise / conversionRestricted Stock Units · Derivative | 2,394 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-033438 · doc4.xml · derivative · entry 6 Kumar Neil · CIK 0001742485 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,518 Underlying: Common Stock · 2,394 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. F6 · derivative.exercise_date: The RSUs vest in sixteen quarterly installments after February 16, 2021, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date, and have no expiration date. F6 · derivative.expiration_date: The RSUs vest in sixteen quarterly installments after February 16, 2021, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date, and have no expiration date. Read SEC document |
| August 16, 2021 Filed Aug 18, 2021 20:06 UTC |
Kumar NeilDirector · CEO and President
|
Exercise / conversionRestricted Stock Units · Derivative | 5,129 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-033438 · doc4.xml · derivative · entry 5 Kumar Neil · CIK 0001742485 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,423 Underlying: Common Stock · 5,129 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. F5 · derivative.exercise_date: The RSUs vest in sixteen quarterly installments after May 16, 2020, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date, and have no expiration date. F5 · derivative.expiration_date: The RSUs vest in sixteen quarterly installments after May 16, 2020, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date, and have no expiration date. Read SEC document |
| August 16, 2021 Filed Aug 18, 2021 20:06 UTC |
Kumar NeilDirector · CEO and President
|
Tax withholdingCommon Stock | 3,730 | $49.48 | $184,560.40 |
DisclosureSEC source: 0000899243-21-033438 · doc4.xml · nonDerivative · entry 2 Kumar Neil · CIK 0001742485 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,719,011 F2 · shares: Represents number of shares of the Issuer's Common Stock withheld to satisfy the Reporting Person's tax obligation in connection with the vesting of 7,523 shares of Common Stock underlying the Reporting Person's RSUs. Read SEC document |
| August 16, 2021 Filed Aug 18, 2021 20:06 UTC |
Kumar NeilDirector · CEO and President
|
Exercise / conversionCommon Stock | 7,523 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-21-033438 · doc4.xml · nonDerivative · entry 1 Kumar Neil · CIK 0001742485 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,722,741 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document |
| August 04, 2021 Filed Aug 6, 2021 22:08 UTC |
SCHELLER RICHARD HDirector · See Remarks
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 13,777 | $0.00 Strike: $17.00 | $0.00 |
DisclosureSEC source: 0000899243-21-031954 · doc4.xml · derivative · entry 3 SCHELLER RICHARD H · CIK 0001214133 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,611 Underlying: Common Stock · 13,777 shares Expires 2029-06-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The shares subject to this option vest and become exercisable in 48 equal monthly installments after June 26, 2019, subject to the Reporting Person's continued service to the Issuer through each such date. Read SEC document |
| August 04, 2021 Filed Aug 6, 2021 22:08 UTC |
SCHELLER RICHARD HDirector · See Remarks
|
SaleCommon Stock | 13,777 | $53.23 | $733,316.65 |
DisclosureSEC source: 0000899243-21-031954 · doc4.xml · nonDerivative · entry 2 SCHELLER RICHARD H · CIK 0001214133 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,860 F1 · price: Represents the weighted average sale price of the shares sold from $52.839 to $53.68 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions as reported in this footnote. Read SEC document |
| August 04, 2021 Filed Aug 6, 2021 22:08 UTC |
SCHELLER RICHARD HDirector · See Remarks
|
Exercise / conversionCommon Stock | 13,777 | $17.00 | $234,209.00 |
DisclosureSEC source: 0000899243-21-031954 · doc4.xml · nonDerivative · entry 1 SCHELLER RICHARD H · CIK 0001214133 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,637 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 17, 2021 Filed Jun 22, 2021 23:15 UTC |
DANIELS RONALD JDirector
|
GrantStock Option (right to buy) · Derivative | 38,895 | $0.00 Strike: $62.63 | $0.00 |
DisclosureSEC source: 0000899243-21-025397 · doc4.xml · derivative · entry 1 DANIELS RONALD J · CIK 0001164475 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,895 Underlying: Common Stock · 38,895 shares Expires 2031-06-16 F1 · derivative.exercise_date: The stock option vests and becomes exercisable in three annual installments after June 17, 2021, subject to the Reporting Person's continued service on the Issuer's Board of Directors through each such date. Read SEC document |
| June 17, 2021 Filed Jun 23, 2021 00:00 UTC |
Satvat Ali J.Director
|
GrantStock Option (right to buy) · Derivative | 38,895 | $0.00 Strike: $62.63 | $0.00 |
DisclosureSEC source: 0000899243-21-025414 · doc4.xml · derivative · entry 1 Satvat Ali J. · CIK 0001621788 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,895 Underlying: Common Stock · 38,895 shares Expires 2031-06-16 F1 · derivative.exercise_date: The stock option vests and becomes exercisable in three annual installments after June 17, 2021, subject to the Reporting Person's continued service on the Issuer's Board of Directors through each such date. Read SEC document |
| June 17, 2021 Filed Jun 22, 2021 23:38 UTC |
Lo AndrewDirector
|
GrantStock Option (right to buy) · Derivative | 38,895 | $0.00 Strike: $62.63 | $0.00 |
DisclosureSEC source: 0000899243-21-025410 · doc4.xml · derivative · entry 1 Lo Andrew · CIK 0001679076 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,895 Underlying: Common Stock · 38,895 shares Expires 2031-06-16 F1 · derivative.exercise_date: The stock option vests and becomes exercisable in three annual installments after June 17, 2021, subject to the Reporting Person's continued service on the Issuer's Board of Directors through each such date. Read SEC document |
| June 17, 2021 Filed Jun 22, 2021 23:16 UTC |
HOMCY CHARLES JDirector
|
GrantStock Option (right to buy) · Derivative | 38,895 | $0.00 Strike: $62.63 | $0.00 |
DisclosureSEC source: 0000899243-21-025398 · doc4.xml · derivative · entry 1 HOMCY CHARLES J · CIK 0001192591 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,895 Underlying: Common Stock · 38,895 shares Expires 2031-06-16 F1 · derivative.exercise_date: The stock option vests and becomes exercisable in three annual installments after June 17, 2021, subject to the Reporting Person's continued service on the Issuer's Board of Directors through each such date. Read SEC document |
| June 17, 2021 Filed Jun 22, 2021 23:21 UTC |
MOMTAZEE JAMES CDirector
|
GrantStock Option (right to buy) · Derivative | 38,895 | $0.00 Strike: $62.63 | $0.00 |
DisclosureSEC source: 0000899243-21-025402 · doc4.xml · derivative · entry 1 MOMTAZEE JAMES C · CIK 0001209181 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,895 Underlying: Common Stock · 38,895 shares Expires 2031-06-16 F1 · derivative.exercise_date: The stock option vests and becomes exercisable in three annual installments after June 17, 2021, subject to the Reporting Person's continued service on the Issuer's Board of Directors through each such date. Read SEC document |
| June 17, 2021 Filed Jun 22, 2021 23:08 UTC |
SAUNDERS BRENT LDirector
|
GrantStock Option (right to buy) · Derivative | 38,895 | $0.00 Strike: $62.63 | $0.00 |
DisclosureSEC source: 0000899243-21-025387 · doc4.xml · derivative · entry 1 SAUNDERS BRENT L · CIK 0001268854 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,895 Underlying: Common Stock · 38,895 shares Expires 2031-06-16 F1 · derivative.exercise_date: The stock option vests and becomes exercisable in three annual installments after June 17, 2021, subject to the Reporting Person's continued service on the Issuer's Board of Directors through each such date. Read SEC document |
| June 17, 2021 Filed Jun 22, 2021 23:03 UTC |
Cook Jennifer E.Director
|
GrantStock Option (right to buy) · Derivative | 38,895 | $0.00 Strike: $62.63 | $0.00 |
DisclosureSEC source: 0000899243-21-025381 · doc4.xml · derivative · entry 1 Cook Jennifer E. · CIK 0001754371 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,895 Underlying: Common Stock · 38,895 shares Expires 2031-06-16 F1 · derivative.exercise_date: The stock option vests and becomes exercisable in three annual installments after June 17, 2021, subject to the Reporting Person's continued service on the Issuer's Board of Directors through each such date. Read SEC document |
| June 17, 2021 Filed Jun 22, 2021 22:51 UTC |
SCHELLER RICHARD HDirector · Chairman of R&D
|
GrantStock Option (right to buy) · Derivative | 38,895 | $0.00 Strike: $62.63 | $0.00 |
DisclosureSEC source: 0000899243-21-025367 · doc4.xml · derivative · entry 1 SCHELLER RICHARD H · CIK 0001214133 · Director · Chairman of R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,895 Underlying: Common Stock · 38,895 shares Expires 2031-06-16 F1 · derivative.exercise_date: The stock option vests and becomes exercisable in three annual installments after June 17, 2021, subject to the Reporting Person's continued service on the Issuer's Board of Directors through each such date. Read SEC document |
| June 17, 2021 Filed Jun 22, 2021 22:47 UTC |
Scott Randal W.Director
|
GrantStock Option (right to buy) · Derivative | 38,895 | $0.00 Strike: $62.63 | $0.00 |
DisclosureSEC source: 0000899243-21-025362 · doc4.xml · derivative · entry 1 Scott Randal W. · CIK 0001337801 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,895 Underlying: Common Stock · 38,895 shares Expires 2031-06-16 F1 · derivative.exercise_date: The stock option vests and becomes exercisable in three annual installments after June 17, 2021, subject to the Reporting Person's continued service on the Issuer's Board of Directors through each such date. Read SEC document |
| June 17, 2021 Filed Jun 22, 2021 22:45 UTC |
AGUIAR ERICDirector
|
GrantStock Option (right to buy) · Derivative | 38,895 | $0.00 Strike: $62.63 | $0.00 |
DisclosureSEC source: 0000899243-21-025359 · doc4.xml · derivative · entry 1 AGUIAR ERIC · CIK 0001262325 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,895 Underlying: Common Stock · 38,895 shares Expires 2031-06-16 F1 · derivative.exercise_date: The stock option vests and becomes exercisable in three annual installments after June 17, 2021, subject to the Reporting Person's continued service on the Issuer's Board of Directors through each such date. Read SEC document |
| May 16, 2021 Filed May 18, 2021 22:28 UTC |
STEPHENSON BRIAN CSee Remarks
|
Exercise / conversionRestricted Stock Units · Derivative | 778 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-019798 · doc4.xml · derivative · entry 4 STEPHENSON BRIAN C · CIK 0001780030 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,671 Underlying: Common Stock · 778 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. F4 · derivative.exercise_date: The RSUs vest in sixteen quarterly installments after February 16, 2021, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date, and have no expiration date. F4 · derivative.expiration_date: The RSUs vest in sixteen quarterly installments after February 16, 2021, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date, and have no expiration date. Read SEC document |
| May 16, 2021 Filed May 18, 2021 22:28 UTC |
STEPHENSON BRIAN CSee Remarks
|
Exercise / conversionRestricted Stock Units · Derivative | 1,710 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-019798 · doc4.xml · derivative · entry 3 STEPHENSON BRIAN C · CIK 0001780030 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,517 Underlying: Common Stock · 1,710 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. F3 · derivative.exercise_date: The RSUs vest in sixteen quarterly installments after May 16, 2020, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date, and have no expiration date. F3 · derivative.expiration_date: The RSUs vest in sixteen quarterly installments after May 16, 2020, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date, and have no expiration date. Read SEC document |
| May 16, 2021 Filed May 18, 2021 22:28 UTC |
STEPHENSON BRIAN CSee Remarks
|
Tax withholdingCommon Stock | 862 | $53.66 | $46,254.92 |
DisclosureSEC source: 0000899243-21-019798 · doc4.xml · nonDerivative · entry 2 STEPHENSON BRIAN C · CIK 0001780030 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 301,669 F2 · shares: Represents number of shares of the Issuer's Common Stock withheld to satisfy the Reporting Person's tax obligation in connection with the vesting of 2,488 shares of Common Stock underlying the Reporting Person's RSUs. Read SEC document |
| May 16, 2021 Filed May 18, 2021 22:28 UTC |
STEPHENSON BRIAN CSee Remarks
|
Exercise / conversionCommon Stock | 2,488 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-21-019798 · doc4.xml · nonDerivative · entry 1 STEPHENSON BRIAN C · CIK 0001780030 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 302,531 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document |
| May 16, 2021 Filed May 18, 2021 22:29 UTC |
Kumar NeilDirector · CEO and President
|
Exercise / conversionRestricted Stock Units · Derivative | 2,394 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-019799 · doc4.xml · derivative · entry 6 Kumar Neil · CIK 0001742485 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,912 Underlying: Common Stock · 2,394 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. F6 · derivative.exercise_date: The RSUs vest in sixteen quarterly installments after February 16, 2021, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date, and have no expiration date. F6 · derivative.expiration_date: The RSUs vest in sixteen quarterly installments after February 16, 2021, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date, and have no expiration date. Read SEC document |
| May 16, 2021 Filed May 18, 2021 22:29 UTC |
Kumar NeilDirector · CEO and President
|
Exercise / conversionRestricted Stock Units · Derivative | 5,130 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-019799 · doc4.xml · derivative · entry 5 Kumar Neil · CIK 0001742485 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,552 Underlying: Common Stock · 5,130 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. F5 · derivative.exercise_date: The RSUs vest in sixteen quarterly installments after May 16, 2020, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date, and have no expiration date. F5 · derivative.expiration_date: The RSUs vest in sixteen quarterly installments after May 16, 2020, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date, and have no expiration date. Read SEC document |
| May 16, 2021 Filed May 18, 2021 22:29 UTC |
Kumar NeilDirector · CEO and President
|
Tax withholdingCommon Stock | 3,731 | $53.66 | $200,205.46 |
DisclosureSEC source: 0000899243-21-019799 · doc4.xml · nonDerivative · entry 2 Kumar Neil · CIK 0001742485 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,715,218 F2 · shares: Represents number of shares of the Issuer's Common Stock withheld to satisfy the Reporting Person's tax obligation in connection with the vesting of 7,524 shares of Common Stock underlying the Reporting Person's RSUs. Read SEC document |
| May 16, 2021 Filed May 18, 2021 22:29 UTC |
Kumar NeilDirector · CEO and President
|
Exercise / conversionCommon Stock | 7,524 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-21-019799 · doc4.xml · nonDerivative · entry 1 Kumar Neil · CIK 0001742485 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,718,949 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 21:05 UTC |
HOMCY CHARLES JDirector
|
Tax withholdingCommon Stock | 524 | $71.91 | $37,680.84 |
DisclosureSEC source: 0000899243-21-009369 · doc4.xml · nonDerivative · entry 2 HOMCY CHARLES J · CIK 0001192591 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,204,764 F1 · shares: Represents number of shares of the Issuer's Common Stock withheld to satisfy the Reporting Person's tax obligation in connection with the grant and issuance of 1,521 vested shares of Common Stock. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 21:05 UTC |
HOMCY CHARLES JDirector
|
GrantCommon Stock | 1,521 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-009369 · doc4.xml · nonDerivative · entry 1 HOMCY CHARLES J · CIK 0001192591 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,205,288 Read SEC document |
| February 17, 2021 Filed Feb 19, 2021 01:33 UTC |
STEPHENSON BRIAN CSee Remarks
|
PurchaseCommon Stock | 8,000 | $62.50 | $500,000.00 |
DisclosureSEC source: 0000899243-21-007227 · doc4.xml · nonDerivative · entry 3 STEPHENSON BRIAN C · CIK 0001780030 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 300,043 Read SEC document |
| February 17, 2021 Filed Feb 19, 2021 00:45 UTC |
Kumar NeilDirector · CEO and President
|
Tax withholdingCommon Stock | 16,000 | $62.50 | $1,000,000.00 |
DisclosureSEC source: 0000899243-21-007211 · doc4.xml · nonDerivative · entry 3 Kumar Neil · CIK 0001742485 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,711,425 Read SEC document |
| February 17, 2021 Filed Feb 18, 2021 23:21 UTC |
Scott Randal W.Director
|
PurchaseCommon Stock | 16,000 | $62.50 | $1,000,000.00 |
DisclosureSEC source: 0000899243-21-007172 · doc4.xml · nonDerivative · entry 1 Scott Randal W. · CIK 0001337801 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,000 Read SEC document |
| February 17, 2021 Filed Feb 17, 2021 22:36 UTC |
KKR Genetic Disorder L.P.10% owner
KKR Genetic Disorder GP LLC10% owner
KKR Group Partnership L.P.10% owner
KKR Group Holdings Corp.10% owner
KKR & Co. Inc.10% owner
KKR Management LLP10% owner
KRAVIS HENRY R10% owner
ROBERTS GEORGE R10% owner
|
SaleCommon Stock | 3,450,000 | $60.47 | $208,617,360.00 |
DisclosureSEC source: 0001140361-21-005267 · form4.xml · nonDerivative · entry 1 KKR Genetic Disorder L.P. · CIK 0001780408 · 10% owner KKR Genetic Disorder GP LLC · CIK 0001780428 · 10% owner KKR Group Partnership L.P. · CIK 0001472698 · 10% owner KKR Group Holdings Corp. · CIK 0001743754 · 10% owner KKR & Co. Inc. · CIK 0001404912 · 10% owner KKR Management LLP · CIK 0001472694 · 10% owner KRAVIS HENRY R · CIK 0001081714 · 10% owner ROBERTS GEORGE R · CIK 0001081715 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 31,060,971 F1 · price: This amount represents the $62.50 secondary public offering price per share of common stock of BridgeBio Pharma, Inc. ("Common Stock") less the underwriting discount of $2.03125 per share for shares sold pursuant to an underwritten public offering F1 · ownership.nature: This amount represents the $62.50 secondary public offering price per share of common stock of BridgeBio Pharma, Inc. ("Common Stock") less the underwriting discount of $2.03125 per share for shares sold pursuant to an underwritten public offering F2 · ownership.nature: The securities of the Issuer are held by KKR Genetic Disorder L.P. KKR Genetic Disorder GP LLC, as the general partner of KKR Genetic Disorder L.P., KKR Group Partnership L.P., as the sole member of KKR Genetic Disorder GP LLC, KKR Group Holdings Corp., as the general partner of KKR Group Partnership L.P., KKR & Co. Inc., as the sole shareholder of KKR Group Holdings Corp., KKR Management LLP, as the Series I preferred stockholder of KKR & Co. Inc., and Messrs. Henry R. Kravis and George R. Roberts, as the founding partners of KKR Management LLP, may be deemed to be the beneficial owners having shared voting and investment power with respect to the shares described above. Each of Messrs. Kravis and Roberts disclaims beneficial ownership of the shares held by KKR Genetic Disorder L.P. F3 · ownership.nature: Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein. The filing of this statement shall not be deemed to be an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, the Reporting Persons are the beneficial owners of any securities reported herein. Read SEC document |
| February 16, 2021 Filed Feb 19, 2021 01:33 UTC |
STEPHENSON BRIAN CSee Remarks
|
Exercise / conversionRestricted Stock Units · Derivative | 1,710 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-007227 · doc4.xml · derivative · entry 4 STEPHENSON BRIAN C · CIK 0001780030 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,227 Underlying: Common Stock · 1,710 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. F4 · derivative.exercise_date: The RSUs vest in sixteen quarterly installments after May 16, 2020, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date, and have no expiration date. F4 · derivative.expiration_date: The RSUs vest in sixteen quarterly installments after May 16, 2020, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date, and have no expiration date. Read SEC document |
| February 16, 2021 Filed Feb 19, 2021 01:33 UTC |
STEPHENSON BRIAN CSee Remarks
|
Tax withholdingCommon Stock | 592 | $64.98 | $38,468.16 |
DisclosureSEC source: 0000899243-21-007227 · doc4.xml · nonDerivative · entry 2 STEPHENSON BRIAN C · CIK 0001780030 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 292,043 F3 · shares: Represents number of shares of the Issuer's Common Stock withheld to satisfy the Reporting Person's tax obligation in connection with the vesting of 1,710 shares of Common Stock underlying the Reporting Person's RSUs. Read SEC document |
| February 16, 2021 Filed Feb 19, 2021 01:33 UTC |
STEPHENSON BRIAN CSee Remarks
|
Exercise / conversionCommon Stock | 1,710 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-21-007227 · doc4.xml · nonDerivative · entry 1 STEPHENSON BRIAN C · CIK 0001780030 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 292,635 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. F2 · balance_after: Includes 840 shares acquired by the Reporting Person on February 12, 2021 pursuant to the Issuer's Employee Stock Purchase Plan in a transaction exempt under Rule 16b-3. Read SEC document |
| February 16, 2021 Filed Feb 19, 2021 00:45 UTC |
Kumar NeilDirector · CEO and President
|
Exercise / conversionRestricted Stock Units · Derivative | 5,129 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-007211 · doc4.xml · derivative · entry 6 Kumar Neil · CIK 0001742485 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,682 Underlying: Common Stock · 5,129 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. F5 · derivative.exercise_date: The RSUs vest in sixteen quarterly installments after May 16, 2020, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date, and have no expiration date. F5 · derivative.expiration_date: The RSUs vest in sixteen quarterly installments after May 16, 2020, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date, and have no expiration date. Read SEC document |
| February 16, 2021 Filed Feb 19, 2021 00:45 UTC |
Kumar NeilDirector · CEO and President
|
Tax withholdingCommon Stock | 2,139 | $64.98 | $138,992.22 |
DisclosureSEC source: 0000899243-21-007211 · doc4.xml · nonDerivative · entry 2 Kumar Neil · CIK 0001742485 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,695,425 F2 · shares: Represents number of shares of the Issuer's Common Stock withheld to satisfy the Reporting Person's tax obligation in connection with the vesting of 5,129 shares of Common Stock underlying the Reporting Person's RSUs. Read SEC document |
| February 16, 2021 Filed Feb 19, 2021 00:45 UTC |
Kumar NeilDirector · CEO and President
|
Exercise / conversionCommon Stock | 5,129 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-21-007211 · doc4.xml · nonDerivative · entry 1 Kumar Neil · CIK 0001742485 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,697,564 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document |
| February 10, 2021 Filed Feb 13, 2021 01:51 UTC |
STEPHENSON BRIAN CSee Remarks
|
GrantRestricted Stock Units · Derivative | 12,449 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-006433 · doc4.xml · derivative · entry 2 STEPHENSON BRIAN C · CIK 0001780030 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,449 Underlying: Common Stock · 12,449 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. F3 · derivative.exercise_date: The units will vest in 16 equal quarterly installments after February 16, 2021, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. F3 · derivative.expiration_date: The units will vest in 16 equal quarterly installments after February 16, 2021, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. Read SEC document |
| February 10, 2021 Filed Feb 13, 2021 01:51 UTC |
STEPHENSON BRIAN CSee Remarks
|
GrantStock Option (Right to Buy) · Derivative | 73,440 | $0.00 Strike: $68.87 | $0.00 |
DisclosureSEC source: 0000899243-21-006433 · doc4.xml · derivative · entry 1 STEPHENSON BRIAN C · CIK 0001780030 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,440 Underlying: Common Stock · 73,440 shares Expires 2031-02-09 F1 · derivative.exercise_date: The option will vest in 48 equal month installments after February 10, 2021, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. Read SEC document |
| February 10, 2021 Filed Feb 13, 2021 01:45 UTC |
Kumar NeilDirector · CEO and President
|
GrantRestricted Stock Units · Derivative | 38,306 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-006432 · doc4.xml · derivative · entry 2 Kumar Neil · CIK 0001742485 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,306 Underlying: Common Stock · 38,306 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. F3 · derivative.exercise_date: The units will vest in 16 equal quarterly installments after February 16, 2021, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. F3 · derivative.expiration_date: The units will vest in 16 equal quarterly installments after February 16, 2021, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. Read SEC document |
| February 10, 2021 Filed Feb 13, 2021 01:45 UTC |
Kumar NeilDirector · CEO and President
|
GrantStock Option (Right to Buy) · Derivative | 225,971 | $0.00 Strike: $68.87 | $0.00 |
DisclosureSEC source: 0000899243-21-006432 · doc4.xml · derivative · entry 1 Kumar Neil · CIK 0001742485 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 225,971 Underlying: Common Stock · 225,971 shares Expires 2031-02-09 F1 · derivative.exercise_date: The option will vest in 48 equal month installments after February 10, 2021, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. Read SEC document |
| January 26, 2021 Filed Jan 29, 2021 01:40 UTC |
Satvat Ali J.Director
|
GrantStock Option (Right to Buy) · Derivative | 79,702 | $0.00 Strike: $10.99 | $0.00 |
DisclosureSEC source: 0000899243-21-003676 · doc4.xml · derivative · entry 3 Satvat Ali J. · CIK 0001621788 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,702 Underlying: Common Stock · 79,702 shares Expires 2028-07-01 F1 · derivative.exercise_date: Pursuant to the terms of the Agreement and Plan of Merger dated October 5, 2020 (the "Merger Agreement"), by and among Eidos Therapeutics, Inc. ("Eidos"), the Issuer, Globe Merger Sub 1, Inc., an indirect wholly owned subsidiary of the Issuer ("Merger Sub"), and Globe Merger Sub II, Inc., an indirect wholly owned subsidiary of the Issuer ("Merger Sub II"), Merger Sub was merged with and into Eidos, with Eidos continuing as the surviving corporation and immediately thereafter, Eidos was merged with and into Merger Sub II, with Merger Sub II continuing as the surviving corporation, effective as of January 26, 2021 (the "Effective Time"). The option became fully vested immediately prior to the Effective Time. F2 · derivative.exercise_date: (Continued from Footnote 1) At the Effective Time, each such option was cancelled, assumed by the Issuer and replaced with an option to purchase 1.85 shares of the Issuer's common stock at an exercise price per share of Parent common stock equal to the exercise price per share of the Issuer option divided by 1.85. Such stock option is subject to the same terms and conditions applicable to the Eidos option immediately prior to the Effective Time. Read SEC document |
| January 26, 2021 Filed Jan 29, 2021 01:40 UTC |
Satvat Ali J.Director
|
GrantStock Option (Right to Buy) · Derivative | 39,851 | $0.00 Strike: $16.68 | $0.00 |
DisclosureSEC source: 0000899243-21-003676 · doc4.xml · derivative · entry 2 Satvat Ali J. · CIK 0001621788 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,851 Underlying: Common Stock · 39,851 shares Expires 2029-06-12 F3 · derivative.exercise_date: The stock option was fully vested. At the Effective Time, each such option was cancelled, assumed by the Issuer and replaced with an option to purchase 1.85 shares of the Issuer's common stock at an exercise price per share of the Issuer's common stock equal to the exercise price per share of the Eidos option divided by 1.85. Such stock option is subject to the same terms and conditions applicable to the Eidos option immediately prior to the Effective Time. Read SEC document |
| January 26, 2021 Filed Jan 29, 2021 01:40 UTC |
Satvat Ali J.Director
|
GrantStock Option (Right to Buy) · Derivative | 39,851 | $0.00 Strike: $26.21 | $0.00 |
DisclosureSEC source: 0000899243-21-003676 · doc4.xml · derivative · entry 1 Satvat Ali J. · CIK 0001621788 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,851 Underlying: Common Stock · 39,851 shares Expires 2030-05-27 F1 · derivative.exercise_date: Pursuant to the terms of the Agreement and Plan of Merger dated October 5, 2020 (the "Merger Agreement"), by and among Eidos Therapeutics, Inc. ("Eidos"), the Issuer, Globe Merger Sub 1, Inc., an indirect wholly owned subsidiary of the Issuer ("Merger Sub"), and Globe Merger Sub II, Inc., an indirect wholly owned subsidiary of the Issuer ("Merger Sub II"), Merger Sub was merged with and into Eidos, with Eidos continuing as the surviving corporation and immediately thereafter, Eidos was merged with and into Merger Sub II, with Merger Sub II continuing as the surviving corporation, effective as of January 26, 2021 (the "Effective Time"). The option became fully vested immediately prior to the Effective Time. F2 · derivative.exercise_date: (Continued from Footnote 1) At the Effective Time, each such option was cancelled, assumed by the Issuer and replaced with an option to purchase 1.85 shares of the Issuer's common stock at an exercise price per share of Parent common stock equal to the exercise price per share of the Issuer option divided by 1.85. Such stock option is subject to the same terms and conditions applicable to the Eidos option immediately prior to the Effective Time. Read SEC document |
| December 28, 2020 Filed Dec 30, 2020 02:14 UTC |
Turtle CameronSee Remarks
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 6,000 | $0.00 Strike: $0.16 | $0.00 |
DisclosureSEC source: 0000899243-20-035444 · doc4.xml · derivative · entry 8 Turtle Cameron · CIK 0001758363 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,042 Underlying: Common Stock · 6,000 shares Expires 2029-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on May 29, 2020. Read SEC document |
| December 28, 2020 Filed Dec 30, 2020 02:14 UTC |
Turtle CameronSee Remarks
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 6,000 | $0.00 Strike: $0.34 | $0.00 |
DisclosureSEC source: 0000899243-20-035444 · doc4.xml · derivative · entry 7 Turtle Cameron · CIK 0001758363 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,766 Underlying: Common Stock · 6,000 shares Expires 2029-07-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on May 29, 2020. Read SEC document |
| December 28, 2020 Filed Dec 30, 2020 02:14 UTC |
Turtle CameronSee Remarks
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 7,500 | $0.00 Strike: $17.00 | $0.00 |
DisclosureSEC source: 0000899243-20-035444 · doc4.xml · derivative · entry 6 Turtle Cameron · CIK 0001758363 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 255,500 Underlying: Common Stock · 7,500 shares Expires 2029-06-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on May 29, 2020. F4 · derivative.exercise_date: The shares subject to this option vest and become exercisable in 48 equal monthly installments after June 26, 2019, subject to the Reporting Person's continued service to the Issuer through each such vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.